AI assistant
Sending…
Nuvectis Pharma, Inc. — Director's Dealing 2023
May 26, 2023
33912_dirs_2023-05-26_6d8ab0a8-f6d0-43ca-b3e2-520477364968.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2023-05-24
Reporting Person: BENTSUR RON (Director, Chairman & CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-24 | Common Stock | P | 200 | $17.49 | Acquired | 3228849 | Direct |
Footnotes
F1: Includes 426,759 shares of restricted stock.
More from Nuvectis Pharma, Inc.
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Regulatory Filings
2026
Feb 23
Capital/Financing Update
2026
Feb 13
Earnings Release
2026
Feb 11
Annual Report
2026
Feb 11
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9